Company: STAA
Filing Date: 2025-09-24
Form Type: DFAN14A
Source: 0001213900-25-091197
Chunk: 19

Company: STAAR SURGICAL CO
Filing Date: 2025-09-24
Form: DFAN14A
Chunk 19
---
 6. See the Company’s proxy statement on Form PREM14A filed with the SEC on August 29, 2025 at 45 - 46. 7. Id. 8. Id. at 46. 9. Id. at 41 - 42. 10. See the Company’s Quarterly Report on Form 10 - Q for the period ended June 27, 2025, filed with the SEC on August 6, 2025 at 23. 11. Id. at 2. 12. See the Company’s Press Release, August 6, 2025, and Quarterly Report on Form 10 - Q for the quarter ended June 27, 2025, filed with the SEC on August 6, 2025. 13. See the Company’s proxy statement on Form PREM14A filed with the SEC on August 29, 2025 at 61. See also FactSet. 14. Vance Thompson Vision, “Measuring Outcomes of LASIK and EVO - ICL in Matched Populations (EVOlve),” NCT06700460. 15. FactSet, data as of September 13, 2025. “Comparable medical technology companies” include Alcon, Alphatec, AtriCure, Axogen, DexCom, Establishment Labs Holdings, Glaukos, Insulet, iRhythm, Penumbra, PROCEPT BioRobotics, TransMedics, Vericel and Treace Medical Concepts. 16. Id. 17. See Needham Research Note, August 5, 2025. 18. See the Company’s proxy statement on Form PREM14A filed with the SEC on August 29, 2025 at 37. 19. Id. at 61. 20. See the Company’s Q1 2025 Earnings Call, available at https://investors.staar.com/~/media/Files/S/staar - surgical/investors/quarter - report/staar - surgical - costaa - us - q1 - 2025 - earnings - call - 07052025.pdf (May 7, 2025). 21. Id. 22. See the Company’s proxy statement on Form PREM14A filed with the SEC on August 29, 2025 at 32. 23. Id. 24. See the Company’s proxy statement on Form PRE